Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of WNT2 mRNA | decreases expression | 18648102
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of WNT2 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of WNT2 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of WNT2 mRNA | affects expression | 16483693
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA | affects cotreatment|decreases expression | 12634122
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in decreased expression of WNT2 mRNA | decreases expression | 18502319
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA | affects cotreatment|decreases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA | affects cotreatment|decreases expression | 12634122
|
D003976 |
Diazinon |
Diazinon results in decreased expression of WNT2 mRNA | decreases expression | 18502319
|
D004026 |
Dieldrin |
Dieldrin results in decreased expression of WNT2 mRNA | decreases expression | 19130878
|
D004958 |
Estradiol |
Estradiol results in increased expression of WNT2 mRNA | increases expression | 15072547
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of WNT2 mRNA | decreases expression | 15072547
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of WNT2 mRNA | increases expression | 15072547
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA | affects cotreatment|decreases expression | 12634122
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of WNT2 mRNA | increases expression | 12634122
|
D009532 |
Nickel |
Nickel results in decreased expression of WNT2 mRNA | decreases expression | 19130878
|
C007350 |
nitrofen |
nitrofen results in decreased expression of WNT2 mRNA | decreases expression | 17270562 18280291
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA | affects cotreatment|decreases expression | 12634122
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of WNT2 mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of WNT2 mRNA | increases expression | 18172886
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of WNT2 mRNA | decreases expression | 17045167
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased methylation of WNT2 promoter | decreases methylation | 20734317
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of WNT2 mRNA | increases expression | 20734317
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of WNT2 protein | increases expression | 20734317
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
13.64 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
13.64 | 14514962 15322242 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
13.64 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.83 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
4.48 | 16166738 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.07 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.69 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.27 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.59 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.80 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
8.81 | 17119214 16611668 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
8.81 | 16487989 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.53 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.13 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.85 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.74 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.48 | 17497229 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.01 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.74 | 11514358 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 11449391 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 17688650 18558336 18316065 19232924 18177632 18940202 15238991 16609825 18985861 19460635 17507914 20603192 18396377 17157402 18775368 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.29 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.91 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.02 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.60 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.60 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.79 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.79 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
2.92 | 15770527 11859874 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.92 | 16675129 17289903 17261762 18497071 14630087 17018787 19861407 12948864 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
2.92 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
2.92 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.92 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.92 | 16873071 16166294 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.48 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.35 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.71 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.05 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.67 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.67 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.67 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.67 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.67 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.62 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.58 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.58 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.31 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
12.00 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
12.00 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
12.00 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.46 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.46 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
15.46 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.46 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.48 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.67 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.06 | 9022650 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.05 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.61 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.61 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.60 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
8.87 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.87 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
7.24 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
nitrofen |
7.24 | 11405365 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
7.24 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
7.24 | 9211117 10589399 9224671 17551590 9142499 8800419 16925845 14991402 9664655 9125849 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
7.24 | 16575769 17688650 8888407 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
6.88 | 2524372 14531868 12868966 8970840 8156756 11298694 11906362 18759878 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
6.88 | 17244072 17100760 19470301 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
9.19 | 3621924 2952479 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
9.19 | 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.32 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
11.67 | 9022650 7440962 6482804 16192314 18648102 9328219 18692083 1440618 9653073 18289764 8291058 6679447 11289319 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
11.67 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.67 | 12958197 17906064 15619225 12153990 16177239 11739529 17522070 11287661 19085960 19416960 14986274 19164858 16109766 12392966 16227642 18713872 15968718 10663392 10774834 11529661 11421492 11743745 19420014 19370779 11834606 16781746 17562736 16081117 11461765 12594235 12705907 16485898 14550746 10915739 16393943 12540782 14725611 2444490 19739265 19923254 18071297 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.67 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
11.67 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.99 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.68 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
4.69 | 16487989 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.94 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.28 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.59 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.59 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.17 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.17 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.92 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.04 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.81 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.88 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.49 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.19 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.96 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.08 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.56 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.56 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.20 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.78 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
10.84 | 19769572 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
10.84 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.91 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.26 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.26 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.57 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.57 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.93 | 17312396 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.93 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.11 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.05 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
nitrofen |
10.97 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.97 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.97 | 14991402 9664655 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
9.23 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
9.23 | 16487989 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.78 | 12621046 16120746 15340226 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
nitrofen |
3.90 | 17618886 16473863 18958481 11588001 7576705 10693666 10541330 12505043 11051153 9575882 10359170 12746050 10646786 10370017 15764645 11685700 16292651 10898224 9473106 7520565 9698600 10898222 16863852 8863223 12021965 16490937 9859898 12194112 12407540 11409163 17270546 16720372 12547725 18280292 7760232 10370016 11584395 15707848 15756563 16080930 11076806 17245593 9476886 15578192 15088113 12904592 15136996 11057544 11329586 12759764 15793718 18280291 15185205 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.93 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.76 | 17263646 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.06 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.65 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.76 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 15340226 8697196 18606429 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.33 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.33 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.46 | 16778211 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.83 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.87 | 18850075 18670907 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
4.83 | 10630421 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
11.06 | 16466525 12948887 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
11.06 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.06 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Nickel |
5.09 | 16166738 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.09 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.89 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.66 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.91 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.59 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.59 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
13.95 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
13.95 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
13.95 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
13.95 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.06 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.06 | 15610895 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.72 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.60 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.82 | 19850784 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.82 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.08 | 17712046 17368321 17107899 17361223 9834237 17339181 19642359 17301526 19035177 19029980 16140955 16823087 17294898 17649720 16788101 16891316 17217047 15748426 16766008 19075265 16935935 17506722 16331271 12679006 19225113 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.23 | 9224671 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.13 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.37 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.37 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.37 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.17 | 19460945 12969438 11587558 16610002 19014921 16611625 19784758 12587719 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
4.17 | 15991261 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.14 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
7.32 | 9539021 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.32 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.32 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
5.50 | 1399818 6587162 3712494 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.50 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
nitrofen |
7.65 | 9859898 16863852 9614859 17245593 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.65 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.16 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.27 | 16712894 19931552 17306315 17077188 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.27 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.49 | 11807958 17203775 16891317 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.38 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.74 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.28 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.28 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.46 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.32 | 16940565 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.78 | 17671175 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.11 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.92 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.19 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.19 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.93 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.19 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.43 | 3581430 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
8.13 | 8820588 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.13 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.13 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.56 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.62 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.71 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.71 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.71 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
16.74 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
16.74 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
16.74 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
16.74 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.78 | 18514411 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
4.09 | 15081274 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.80 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
8.80 | 14694615 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.91 | 3988306 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.67 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.67 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.67 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.29 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.29 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.42 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.38 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
3.48 | 16809432 11181820 11445065 16112328 17291500 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.36 | 6228378 |
MESH:D011041 |
Poisoning |
|
Diazinon |
4.25 | 17603234 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.10 | 11896295 11222880 11118676 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.10 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.78 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.27 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.27 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.50 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.44 | 11422049 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.68 | 16723453 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
4.53 | 16611668 11874814 17119214 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
4.79 | 16611668 17119214 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.29 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.51 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.51 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.05 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.66 | 16876388 11044598 14763951 3137016 15475178 11738929 17978042 1511512 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.98 | 6418539 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.13 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.13 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.13 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.26 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.26 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.44 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.79 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.85 | 7505956 1399818 6587162 3712494 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.85 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.58 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.69 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.13 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.16 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.41 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.95 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
4.95 | 17306315 16452187 11723127 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.53 | 8888407 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
5.17 | 16487989 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.87 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.08 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.08 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.50 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.32 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.95 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.87 | 16287080 |